Comparison

ALIGN TECHNOLOGY INC (ALGN) vs BOSTON SCIENTIFIC CORP (BSX)

The same filed metrics for both companies, side by side.

What each names as a risk in its own annual report, how each is priced against its own history, and the tracked managers whose latest 13F reports a position in both.

Financials

ALGN

ALIGN TECHNOLOGY INC

Medical Devices

Revenue, FY25: $4.03B
Net income: $410M
Operating cash flow: $593M
Free cash flow: $491M
Net margin: 10.17%
Operating margin: 13.53%
Gross margin: 67.19%

BSX

BOSTON SCIENTIFIC CORP

Medical Devices

Revenue, FY25: $20.07B
Net income: $2.89B
Operating cash flow: $4.53B
Free cash flow: $3.66B
Net margin: 14.41%
Operating margin: 18.00%
Gross margin: 69.01%

Head-to-head

Filed growth, quality and valuation, read against each company’s own history rather than against the other side.

Metric	ALGN	BSX
Revenue growth, latest filed year	+0.90%	+19.87%
Piotroski F-score	6 of 8	7 of 9
P/E against its own history	37.50% below	71.57% below

What each says it is exposed to

From Item 1A of each company’s most recent 10-K.

ALGN

Cybersecurity
Litigation
Tax
Currency moves
Supply chain
Tariffs

And 21 more.

BSX

FDA approval
Litigation
Reimbursement
Product recalls
Goodwill impairment
Tax

And 20 more.

Tracked managers holding both

Joel Greenblatt Gotham Asset Management 0.07% · 0.04%

Updated Sep 8, 2026 · the newer of the two companies' filings